product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-FoxO3a (Ser413) (D77C9) Rabbit mAb
catalog :
8174
clonality :
monoclonal
host :
rabbit
conjugate :
nonconjugated
antigen modification :
phosphorylated
clone name :
D77C9
reactivity :
human, mouse
application :
western blot, immunoprecipitation
citations: 2
Published Application/Species/Sample/DilutionReference
  • western blot; human; loading ...; fig 6e
Tanaka N, Zhao M, Tang L, Patel A, Xi Q, Van H, et al. Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1. Oncogene. 2018;37:1279-1292 pubmed publisher
  • western blot; mouse; loading ...; fig 3i
Shin H, Kim H, Oh S, Lee J, Kee M, Ko H, et al. AMPK-SKP2-CARM1 signalling cascade in transcriptional regulation of autophagy. Nature. 2016;534:553-7 pubmed publisher
product information
SKU :
8174S
Product-Name :
Phospho-FoxO3a (Ser413) (D77C9) Rabbit mAb
Size :
100 ul
Price-(USD) :
274 USD
Species-x-Reactivity :
H
Applications :
Immunoprecipitation
Product-Category :
PI3K / Akt Signaling
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
82-97
Host :
Rabbit
Target :
FoxO3a (Ser413) phosphate
Primary-Protein :
FOXO3A
Alt-Names :
AF6q21,AF6q21 protein,DKFZp781A0677,FKHRL1,FKHRL1P2,FOXO2,FOXO3,FOXO3A,Forkhead box protein O3,Forkhead in rhabdomyosarcoma-like 1,MGC12739,MGC31925,forkhead box O3,forkhead box O3A,forkhead homolog (rhabdomyosarcoma) like 1,forkhead, Drosophila, homolog of, in rhabdomyosarcoma-like 1
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.